Insider · CIK 0001861844

GOYAL ARJUN

Reports to the SEC for 3 companies · WESTFIELD, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001861844

Forms 4 and 5

Insider transactions

21 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−64.6K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−48K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcD Disposition to Issuer	Director	DDisposition to Issuer	−463K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−40K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−48K sh	—	—	0
2026-06-24	Centessa Pharmaceuticals plcShare Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−48K sh	—	—	0
2025-06-20	Centessa Pharmaceuticals plcShare Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2025-05-16	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+418K sh	$12.73	+$5.32M	462,585
2025-05-15	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+44.9K sh	$12.24	+$550K	44,939
2024-06-25	Centessa Pharmaceuticals plcShare Option (right to buy)A Award	Director	AAward	+48K sh	—	—	48,000
2023-06-22	Centessa Pharmaceuticals plcShare Option (right to buy)A Award	Director	AAward	+48K sh	—	—	48,000
2022-06-30	Centessa Pharmaceuticals plcShare Option (right to buy)A Award	Director	AAward	+48K sh	—	—	48,000
2021-07-01	Centessa Pharmaceuticals plcShare Option (right to buy)A Award	Director	AAward	+64.6K sh	—	—	64,570
2021-06-02	Centessa Pharmaceuticals plcC Conversion	Director	CConversion	+3.1M sh	—	—	3,095,909
2021-06-02	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+20.3K sh	$20.00	+$405K	106,159
2021-06-02	Centessa Pharmaceuticals plcC Conversion	Director	CConversion	+85.9K sh	—	—	85,909
2021-06-02	Centessa Pharmaceuticals plcP Purchase	Director	PPurchase	+730K sh	$20.00	+$14.6M	3,825,659
2021-06-02	Centessa Pharmaceuticals plcSeries A Preferred SharesC Conversion	Director	CConversion	−3.1M sh	—	—	0
2021-06-02	Centessa Pharmaceuticals plcSeries A Preferred SharesC Conversion	Director	CConversion	−85.9K sh	—	—	0
2021-01-29	Centessa Pharmaceuticals plcSeries A Preferred SharesA Award	Director	AAward	+3.1M sh	$11.00	+$34.1M	3,095,909
2021-01-29	Centessa Pharmaceuticals plcSeries A Preferred SharesA Award	Director	AAward	+85.9K sh	$11.00	+$945K	85,909

Recent filings

Accepted (ET)
Jun 244
GOYAL ARJUN0001470831-26-000613
SEC(opens sec.gov)
Jun 244
GOYAL ARJUN0001847903-25-000109
SEC(opens sec.gov)
May 194
GOYAL ARJUN0001847903-25-000074
SEC(opens sec.gov)
Jun 274
GOYAL ARJUN0001847903-24-000107
SEC(opens sec.gov)
Jun 234
GOYAL ARJUN0001847903-23-000124
SEC(opens sec.gov)
Jul 54
GOYAL ARJUN0000899243-22-025103
SEC(opens sec.gov)
Jul 64
GOYAL ARJUN0000899243-21-027618
SEC(opens sec.gov)
Jun 44
GOYAL ARJUN0000899243-21-022066
SEC(opens sec.gov)

Companies

Address

C/O JATT III ACQUISITION CORP 53 CENTRAL AVENUE C/O 56

WESTFIELD, NJ, 07091